Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 1,265,500 | 638,300 | 2,684,200 | 2,007,482 | 1,360,206 |
| Accounts payable and accrued liabilities | -1,084,900 | -560,300 | -2,240,500 | -1,722,173 | -1,173,285 |
| Other Working Capital | 105,100 | 51,800 | 266,600 | 197,949 | 131,830 |
| Other Operating Activity | -118,300 | -60,000 | -335,400 | -189,362 | -122,566 |
| Operating Cash Flow | $167,400 | $69,800 | $374,900 | $293,896 | $196,185 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,400 | -2,900 | 174,200 | 62,342 | 27,836 |
| PPE Investments | -82,400 | -40,200 | -156,500 | -114,331 | -70,325 |
| Net Acquisitions | N/A | N/A | 2,500 | N/A | N/A |
| Investing Cash Flow | $-74,000 | $-43,100 | $20,200 | $-51,989 | $-42,489 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -300 | -200 | -500 | -349 | -231 |
| Common Stock Issued | 10,200 | 5,500 | 18,500 | 14,168 | 9,521 |
| Common Stock Repurchased | -105,700 | -4,700 | -428,700 | -228,728 | -207,407 |
| Other Financing Activity | -800 | -600 | -14,900 | -10,118 | -312 |
| Financing Cash Flow | $-96,600 | $0 | $-425,600 | $-225,027 | $-198,429 |
| Exchange Rate Effect | 6,500 | 2,700 | 400 | 6,891 | 670 |
| Beginning Cash Position | 404,400 | 404,400 | 434,500 | 434,544 | 434,544 |
| End Cash Position | 407,700 | 433,800 | 404,400 | 458,315 | 390,481 |
| Net Cash Flow | $3,300 | $29,400 | $-30,100 | $23,771 | $-44,063 |
| Free Cash Flow | |||||
| Operating Cash Flow | 167,400 | 69,800 | 374,900 | 293,896 | 196,185 |
| Capital Expenditure | -82,500 | -40,200 | -156,700 | -114,435 | -70,364 |
| Free Cash Flow | 84,900 | 29,600 | 218,200 | 179,461 | 125,821 |